Research and analysis

ACMD Naloxone Review

The Advisory Council on the Misuse of Drugs has undertaken a review of the availability and implementation of naloxone in the UK.



The Advisory Council of the Misuse of Drugs (ACMD) has reviewed the evidence on the provision and availability of naloxone, a medicine which can temporarily reverse the effects of opioids and is used as an emergency treatment for people who overdose on these drugs. The findings of this review, and recommendations to optimise the use of naloxone are presented in this report.

The government response to this report was published on 25 September 2023.

Updates to this page

Published 17 June 2022
Last updated 26 September 2023 + show all updates
  1. Government response added to page.

  2. First published.

Sign up for emails or print this page